Exane Derivatives Paramount Group, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Paramount Group, Inc. stock. As of the latest transaction made, Exane Derivatives holds 71 shares of PGRE stock, worth $345. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71
Previous 71
-0.0%
Holding current value
$345
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PGRE
# of Institutions
191Shares Held
139MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY31.1MShares$151 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA26.4MShares$129 Million0.0% of portfolio
-
Long Pond Capital, LP New York, NY8.94MShares$43.5 Million2.17% of portfolio
-
State Street Corp Boston, MA8.18MShares$39.9 Million0.0% of portfolio
-
Jupiter Asset Management LTD7.66MShares$37.3 Million0.34% of portfolio
About Paramount Group, Inc.
- Ticker PGRE
- Exchange NYSE
- Sector Real Estate
- Industry REIT—Office
- Shares Outstandng 219,824,000
- Market Cap $1.07B
- Description
- Headquartered in New York City, Paramount Group, Inc. is a fully-integrated real estate investment trust that owns, operates, manages, acquires and redevelops high-quality, Class A office properties located in select central business district submarkets of New York City and San Francisco. Paramount is focused on maximizing the value of its portf...